1 |
Development of Methods to Modulate Natural Killer CellsShaver, Kari A 01 January 2018 (has links) (PDF)
Natural Killer (NK) cell based immunotherapies have demonstrated success against malignancies and hematological cancers. However, tumors have developed mechanisms to evade detection by and suppress the immune system, commonly through altering the expression of cell-surface proteins. Overexpression of human leukocyte antigen-E (HLA-E), which binds to the inhibitory NKG2A on NK cells, protects malignant cells from lysis. Downregulating the NKG2A receptor on NK cells should release NK cell inhibition, but proves challenging as NK cells are difficult to transfect and no good methods currently exist. This project is designed to investigate the use of exosomes – small vesicles and natural carriers of regulatory microRNAs (miRNAs) and proteins that are shed from cells – as delivery vehicles for small RNAs (sRNAs) to immune cells. Exosomes are biologically compatible, immunologically inert, and interact with target cells through receptor-ligand interactions, allowing for targeted delivery of cargo. Exosomes loaded with shRNA against NKG2A were cultured in vitro with NK cells. Delivery success was assessed by monitoring NKG2A receptor expression on NK cells through flow cytometry. This research will provide valuable information that will likely impact the delivery of RNA therapeutics and unlock the full cytotoxic potential of NK immunotherapy.
|
2 |
Avaliação de aspectos inatos e adaptativos do sistema imune na psoríase: análise fenotípica e funcional de células natural killer e células T / Innate and adaptive features of the immune system in psoriasis: phenotypic and functional analyses of natural killer cells and T cellsBatista, Mariana Dias 06 December 2012 (has links)
INTRODUÇÃO: A psoríase é doença inflamatória hiperproliferativa da pele, na qual mecanismos imunológicos são cruciais para o processo patogênico. O marcador CD57 denota inabilidade de replicação e imuno-senescência de células T CD8+, e sua expressão foi demonstrada em diversas condições inflamatórias. CD57 também pode ser expresso por células natural killer (NK), nas quais é considerado marcador de maturidade, por ser em geral adquirido pelas formas mais diferenciadas CD56+CD16+. A expressão de CD57 e outros receptores de células NK não foi amplamente investigada na psoríase. OBJETIVOS: Este estudo buscou examinar o fenótipo de células NK em biópsias de pele e células mononucleares do sangue periférico (CMSP) de pacientes com psoríase em relação a controles sadios. Este estudo investigou também o fenótipo e características funcionais de células T isoladas da pele lesional e não afetada de pacientes com psoríase. MÉTODOS: Foram isoladas células NK dos subtipos CD56+CD16- e CD56+CD16+ de pele lesional, não afetada e CMSP de pacientes com psoríase, comparadas com pele normal e CMSP de controles sadios. A expressão de CD57, NKG2A e NKG2C foi determinada nesses subtipos de células por citometria de fluxo. Células T CD4+ e CD8+ foram isoladas da pele lesional e não afetada de pacientes com psoríase, e a expressão de CD57 foi avaliada. Características funcionais de células T foram estudadas através da análise da secreção de diversas citocinas inflamatórias (IL-17A, IFN-\", IL-2, IL-33, TNF- #, IL-21, IL-22 and IL-27) produzidas por células T CD4+ e CD8+ isoladas por sorting celular, a partir de amostras de pele lesional e não afetada de pacientes com psoríase. RESULTADOS: Células NK isoladas das lesões de psoríase apresentaram um fenótipo particular, caracterizado por baixa expressão de CD57 e alta expressão de NKG2A na pele lesional e não afetada em relação aos controles. Em relação às células T, encontrouse frequência de células T CD4+CD57+ e CD8+CD57+ significativamente maior na pele não afetada em relação à pele lesional de pacientes com psoríase. Células T CD4+ isoladas por sorting celular a partir de amostras de pele lesional produziram níveis maiores de IL-17A, IL-22 e IFN-\" em relação às amostras de pele não afetada. Células T CD8+ isoladas da pele lesional secretaram maiores níveis de IL-17A, IFN-\", TNF-# e IL- 2 em relação à pele não afetada. CONCLUSÕES: Esses dados sugerem que células NK presentes nas lesões de psoríase apresentam fenótipo imaturo, que foi previamente associado a maiores capacidades funcionais, e poderiam ser implicadas na patogênese da psoríase. Em relação às células T, as características fenotípicas sugerem menor sobrevivência de células com baixa capacidade replicativa na pele lesional, pelo ambiente inflamatório local ou pelo alto turnover celular da psoríase / INTRODUCTION: Psoriasis is a hyper-proliferative inflammatory disease of the skin in which immunological mechanisms play a direct role in disease pathogenesis. CD57 is a marker of replicative inability and immunosenescence on CD8+ T cells and its expression is increased in a number of inflammatory conditions. CD57 is also expressed by NK cells and is considered a marker of NK cell maturity, being acquired by more differentiated CD56+CD16+ NK cells. The expression of CD57 and other NK cell markers in psoriasis has not been thoroughly investigated. OBJECTIVES: This study sought to examine the phenotype of NK cells in skin biopsies and peripheral blood mononuclear cells (PBMC) from patients with psoriasis and healthy controls. We also investigated the phenotype and functional characteristics of T cells from psoriasis patients, comparing lesional and unaffected skin. METHODS: CD56+CD16- and CD56+CD16+ NK cells were isolated from lesional skin, unaffected skin and PBMC of psoriasis patients, and normal skin and PBMC from healthy controls. The expression of CD57, NKG2A, and NKG2C was assessed by flow cytometry. CD57 expression was also determined on T cells from lesional and unaffected skin by flow cytometry. We assessed functional characteristics of T cells by evaluating the secretion of several inflammatory cytokines (IL-17A, IFN-\", IL- 2, IL-33, TNF-#, IL-21, IL-22 and IL-27), from cell-sorted purified CD4+ and CD8+ T cells isolated from lesional and unaffected skin of psoriasis patients, by multiplex assays. RESULTS: NK cells in psoriasis skin lesions exhibited a distinct phenotype, with CD57 expression significantly reduced and NKG2A expression increased on NK cells in lesional and unaffected skin compared to controls. In relation to T cells, we observed that the frequency of CD57+CD4+ and CD57+CD8+ T cells was significantly increased in unaffected skin of psoriasis patients compared to lesional skin. Sorted CD4+ T cells from psoriasis lesional skin produced higher levels of IL-17A, IL-22 and IFN-\" compared to unaffected skin. CD8+ T cells isolated from lesional skin produced higher levels of IL- 17A, IFN-\", TNF-# and IL-2 compared to unaffected skin. CONCLUSIONS: These data suggest that NK cells in psoriasis lesions exhibit an immature phenotype, that has been previously associated with higher functional abilities, and could implicate NK cells in psoriasis pathogenesis. For T cells, the findings of this study suggest lower survival of cells with low replicative ability in lesional skin, due to the local inflammatory environment or to the high cellular turnover in psoriasis
|
3 |
Le FCyRIIIa/CD16A des cellules Natural Killer (NK) humaines : régulation de son expression et variabilité des réponses fonctionnelles induites par son engagement / The FcgammaRIIIA/CD16A of human natural killer (NK) cells : regulation of expression and variability in the functional responses induced by its engagementLajoie, Laurie 02 July 2014 (has links)
L’activation des cellules NKCD56dim par l’engagement ou non du récepteur FγRIIIA/CD16A entraîne la perte d’expression membranaire de celui-ci par un mécanisme dépendant au moins en partie de la metalloprotéase ADAM17. Celle-ci clive le récepteur entre l’Alanine 195 et la Valine 196 et agit exclusivement en cis. La modulation d’expression du FγRIIIA/CD16A est un marqueur d’activation des cellules NK plus fortement corrélé à la dégranulation qu’à la production d’IFN-γ. L’engagement du récepteur FγRIIIA/CD16A ou le co-engagement des récepteurs activateurs des NKCD56dim induisent de manière non corrélée la dégranulation et la production d’IFN-γ. Cette dichotomie fonctionnelle varie selon les donneurs et dépend de l’expression des récepteurs inhibiteurs spécifiques des molécules du CMH-I. La production d’IFN-γ est ainsi associée à l’expression des KIRs (Killer like-Immunoglobuline Receptor) mais pas à celle du NKG2A. Une meilleure compréhension des réponses effectrices dépendantes du FγRIIIA/CD16A est importante pour améliorer l’efficacité thérapeutique des anticorps monoclonaux à visée anti-tumorale. / FγRIIIA/CD16A-dependent or independent activation of CD56dim NK cells induces down-modulation of this receptor. The mechanism partially involves the ADAM17 metalloprotease, which cleaves the FγRIIIA/CD16A between Alanine 195 and Valine 196 and acts exclusively in cis. FγRIIIA/CD16A downmodulation is a marker of NK cell activation more strongly correlated with degranulation than to IFN-γ- production. FγRIIIA/CD16A engagement or activating receptors co-engagement on CD56dim NK cell induces degranulation and IFN-γ-production, which are not correlated. This functional dichotomy depends on the donor and on the CMH-I-specific inhibitory receptor expression. IFN-γ-production is thus associated with KIRs (Killer like-Immunoglobuline Receptor) but not with NKG2A expression. Understanding the FγRIIIA/CD16Adependent functional responses is essential to improve the efficacy of monoclonal antibodies used in cancer therapy.
|
4 |
Avaliação de aspectos inatos e adaptativos do sistema imune na psoríase: análise fenotípica e funcional de células natural killer e células T / Innate and adaptive features of the immune system in psoriasis: phenotypic and functional analyses of natural killer cells and T cellsMariana Dias Batista 06 December 2012 (has links)
INTRODUÇÃO: A psoríase é doença inflamatória hiperproliferativa da pele, na qual mecanismos imunológicos são cruciais para o processo patogênico. O marcador CD57 denota inabilidade de replicação e imuno-senescência de células T CD8+, e sua expressão foi demonstrada em diversas condições inflamatórias. CD57 também pode ser expresso por células natural killer (NK), nas quais é considerado marcador de maturidade, por ser em geral adquirido pelas formas mais diferenciadas CD56+CD16+. A expressão de CD57 e outros receptores de células NK não foi amplamente investigada na psoríase. OBJETIVOS: Este estudo buscou examinar o fenótipo de células NK em biópsias de pele e células mononucleares do sangue periférico (CMSP) de pacientes com psoríase em relação a controles sadios. Este estudo investigou também o fenótipo e características funcionais de células T isoladas da pele lesional e não afetada de pacientes com psoríase. MÉTODOS: Foram isoladas células NK dos subtipos CD56+CD16- e CD56+CD16+ de pele lesional, não afetada e CMSP de pacientes com psoríase, comparadas com pele normal e CMSP de controles sadios. A expressão de CD57, NKG2A e NKG2C foi determinada nesses subtipos de células por citometria de fluxo. Células T CD4+ e CD8+ foram isoladas da pele lesional e não afetada de pacientes com psoríase, e a expressão de CD57 foi avaliada. Características funcionais de células T foram estudadas através da análise da secreção de diversas citocinas inflamatórias (IL-17A, IFN-\", IL-2, IL-33, TNF- #, IL-21, IL-22 and IL-27) produzidas por células T CD4+ e CD8+ isoladas por sorting celular, a partir de amostras de pele lesional e não afetada de pacientes com psoríase. RESULTADOS: Células NK isoladas das lesões de psoríase apresentaram um fenótipo particular, caracterizado por baixa expressão de CD57 e alta expressão de NKG2A na pele lesional e não afetada em relação aos controles. Em relação às células T, encontrouse frequência de células T CD4+CD57+ e CD8+CD57+ significativamente maior na pele não afetada em relação à pele lesional de pacientes com psoríase. Células T CD4+ isoladas por sorting celular a partir de amostras de pele lesional produziram níveis maiores de IL-17A, IL-22 e IFN-\" em relação às amostras de pele não afetada. Células T CD8+ isoladas da pele lesional secretaram maiores níveis de IL-17A, IFN-\", TNF-# e IL- 2 em relação à pele não afetada. CONCLUSÕES: Esses dados sugerem que células NK presentes nas lesões de psoríase apresentam fenótipo imaturo, que foi previamente associado a maiores capacidades funcionais, e poderiam ser implicadas na patogênese da psoríase. Em relação às células T, as características fenotípicas sugerem menor sobrevivência de células com baixa capacidade replicativa na pele lesional, pelo ambiente inflamatório local ou pelo alto turnover celular da psoríase / INTRODUCTION: Psoriasis is a hyper-proliferative inflammatory disease of the skin in which immunological mechanisms play a direct role in disease pathogenesis. CD57 is a marker of replicative inability and immunosenescence on CD8+ T cells and its expression is increased in a number of inflammatory conditions. CD57 is also expressed by NK cells and is considered a marker of NK cell maturity, being acquired by more differentiated CD56+CD16+ NK cells. The expression of CD57 and other NK cell markers in psoriasis has not been thoroughly investigated. OBJECTIVES: This study sought to examine the phenotype of NK cells in skin biopsies and peripheral blood mononuclear cells (PBMC) from patients with psoriasis and healthy controls. We also investigated the phenotype and functional characteristics of T cells from psoriasis patients, comparing lesional and unaffected skin. METHODS: CD56+CD16- and CD56+CD16+ NK cells were isolated from lesional skin, unaffected skin and PBMC of psoriasis patients, and normal skin and PBMC from healthy controls. The expression of CD57, NKG2A, and NKG2C was assessed by flow cytometry. CD57 expression was also determined on T cells from lesional and unaffected skin by flow cytometry. We assessed functional characteristics of T cells by evaluating the secretion of several inflammatory cytokines (IL-17A, IFN-\", IL- 2, IL-33, TNF-#, IL-21, IL-22 and IL-27), from cell-sorted purified CD4+ and CD8+ T cells isolated from lesional and unaffected skin of psoriasis patients, by multiplex assays. RESULTS: NK cells in psoriasis skin lesions exhibited a distinct phenotype, with CD57 expression significantly reduced and NKG2A expression increased on NK cells in lesional and unaffected skin compared to controls. In relation to T cells, we observed that the frequency of CD57+CD4+ and CD57+CD8+ T cells was significantly increased in unaffected skin of psoriasis patients compared to lesional skin. Sorted CD4+ T cells from psoriasis lesional skin produced higher levels of IL-17A, IL-22 and IFN-\" compared to unaffected skin. CD8+ T cells isolated from lesional skin produced higher levels of IL- 17A, IFN-\", TNF-# and IL-2 compared to unaffected skin. CONCLUSIONS: These data suggest that NK cells in psoriasis lesions exhibit an immature phenotype, that has been previously associated with higher functional abilities, and could implicate NK cells in psoriasis pathogenesis. For T cells, the findings of this study suggest lower survival of cells with low replicative ability in lesional skin, due to the local inflammatory environment or to the high cellular turnover in psoriasis
|
5 |
Structural features underlying antigen presentation by the non-classical MHC class Ib molecule Qa-1bAI-Tamimi, Lejla January 2022 (has links)
Blockering av NKG2A receptorn på NK - och CD8+ T celler med en anti-NKG2A antikropp, medför en aktivering av cytolytisk aktivitet, och är en lovande immunkontrollpunkt i immunterapi mot cancer. Nyligen har en TCR-liknande antikropp, EXX1, som binder till liganden för NKG2A receptorn, Qa-1b - en icke-klassisk MHC klass Ib molekyl i möss -studerats i tumör modeller in vitro. Resultat påvisar att den TCR-liknande antikroppen endast binder till Qa-1b om denna presenterar Qdm peptiden på sin yta, som erhålls från ledarsekvensen hos klassika MHC klass Ia H-2D. Detta väcker frågor kring strukturella faktorer som möjliggör antigenpresentation på Qa-1b och de exakta molekylära parametrarna som ger upphov till antikroppens specificitet. Syftet med denna studie var att bestämma och jämföra kristallstrukturerna för Qa-1b med Qdm (AMAPRTLLL) samt peptid 001 (AQAERTPEL). Den tunga peptidkedjan hos Qa-1b och beta-2-mikroglobulin producerades rekombinant i E.coli, återveckades med respektive peptid, renades med kromatografimetoder och slutligen kristalliserades genom ångdiffusionsmetoden med hängande droppar. Värmestabilitet hos MHC/peptid undersöktes med nano differential scanning fluorimetry, där Qa-1b /001 uppvisade bättre stabilitet. Kristaller för Qa-1b /Qdm och Qa-1b /001 kunde erhållas med 8% PEG4000, 10mM NiCl2, 0.1M natriumacetat vid pH 5.7, respektive 10% PEG4000, 10 mM NiCl2 och 0.1 M natriumacetat vid pH 6.0. Strukturen för Qa-1b /001 kunde bestämmas vid 2.43 Å med molekylär ersättning. Med anledning av negativt laddade sidogrupper i peptid 001 som har en ytlig konformation i bindningsfickan, kan avsaknaden av bindning till EXX1 förklaras av en skillnad i elektrostatiska interaktioner mellan Qdm och peptid 001. Ytterligare strukturella karakteriseringar av Qa-1b komplexen med antikroppen är av fortsatt stort intresse. / Blocking of the NKG2A receptor expressed on NK cells and CD8+ T cells with an anti-NKG2A antibody for elicitation of cytolytic activity, is a promising immune checkpoint in cancer immunotherapy. EXX1, a novel TCR-like antibody with specificity for the NKG2A ligand, Qa-1b - a murine non-classical MHC class Ib ortholog of HLA-E - has been assessed in tumor models in vitro. The antibody only engages with Qa-1b when it presents the dominant peptide Qdm, derived from the leader sequence of the classical MHC class Ia H-2D. This raises questions about the structural features of antigen presentation by Qa-1b, and the molecular parameters driving the specificity of the TCR-like antibody. The purpose of this study is to determine and compare the crystal structures of Qa-1b in complex with Qdm (AMAPRTLLL) and peptide 001 (AQAERTPEL). The Qa-1b heavy chain and mouse beta-2 microglobulin were recombinantly expressed in E.coli, refolded in the presence of respective peptide, purified using size exclusion chromatography and crystallized with the hanging drop vapor diffusion method. Thermal stability of the MHC/peptide complexes was assessed with nano differential scanning fluorimetry, implying a higher stability of Qa-1b/001. Crystals of the Qa-1b/Qdm and Qa-1b/001 were obtained with 8% PEG4000, 10 mM NiCl2, 0.1 M sodium acetate at pH 5.7, and 10% PEG4000, 10mM NiCl2 and 0.1 M sodium acetate at pH 6.0, respectively. The structure of Qa-1b/001 was resolved by molecular replacement at 2.43 Å, and the presence of negatively charged side chains that protrude from the binding groove, may imply that differences in electrostatic interactions between Qdm and 001 will determine antibody-binding. Further structural characterizations, of Qa-1b complexes with bound EXX1 are of great interest.
|
6 |
L’ingénierie des cellules NK entant que nouvelle immunothérapie ciblée contre le rhabdomyosarcomeBenhaddou, Soraya 06 1900 (has links)
Le rhabdomyosarcome (RMS) est le cancer des tissus mous le plus courant chez l'enfant, et moins de 30 % des patients à haut risque obtiennent une rémission. Par conséquent, il existe un besoin pour une immunothérapie nouvelle et efficace. Les cellules tueuses naturelles (NK), avec leur capacité intrinsèque à tuer les cellules cancéreuses, représentent un outil thérapeutique prometteur. Cependant, leur efficacité clinique est limitée. Ainsi, nous proposons de concevoir ces cellules avec un récepteur antigénique chimérique (CAR) qui permettra aux cellules NK de cibler plus efficacement les cellules de RMS. De plus, nous proposons aussi de concevoir grâce à la technologie CRISPR-Cas9, des NK n’exprimant pas NKG2A, un récepteur impliqué dans l'inhibition des cellules NK par le microenvironnement tumoral.
Nous avons développé un vecteur lentiviral codant pour une construction CAR reconnaissant B7-H3 et FGFR4, deux protéines surexprimées à la surface des cellules RMS, associées à une queue intracellulaire optimisée pour l'activation des NK. Les cellules NK primaires expandues ont été transduites et triées en fonction de l'expression du CAR, conduisant à une population de cellules CAR+- NK enrichie. L'efficacité des deux CAR a été évaluée par des tests cytotoxiques et de dégranulation contre les lignées cellulaires de RMS, RH-30 et RD, toutes deux exprimant B7-H3 et FGFR4. Les résultats préliminaires ont montré une augmentation de la cytotoxicité de 20 % par rapport aux NK de type sauvage pour les CAR anti-B7-H3. Les cellules NK ont également été transduites pour éliminer l’expression du gène KLRC1, codant pour NKG2A, en utilisant CRISPR Cas9. Ceci a permis d’augmenter la cytotoxicité des NK de 20% à 25% comparativement aux NK qui expriment NKG2A. Nous avons aussi combiné les deux modifications génétiques, obtenant ainsi des NK qui expriment un CAR contre les cellules du RMS et n’exprimant pas NKG2A. Des résultats préliminaires nous ont permis d’observer que les NK doublement modifiées étaient 60% plus cytotoxiques que les NK non-transduites et 20% plus efficaces que les CAR-NK ou les NK n’exprimant pas NKG2A.
Ce projet sera une preuve de principe qu'une thérapie hautement innovante basée sur l'ingénierie des cellules NK est efficace et applicable au cancer solide. / Rhabdomyosarcoma (RMS) is the most common soft tissue cancer in childhood, and less than
30% of high-risk patients achieve remission. Therefore, there is a need for new and efficient
immunotherapy. Natural killer (NK) cells, with their intrinsic ability to kill cancer cells, represent
a promising therapeutic tool. However, their clinical efficacy is limited. Thus, we propose to
engineer these cells with a Chimeric Antigen Receptor (CAR) that will allow NK cells to target RMS
cells more efficiently and though the knock-out of NKG2A, a receptor involved in the inhibition of
NK cells by the tumor microenvironment.
We developed a lentiviral vector coding for a CAR construct recognizing B7-H3 and FGFR4, two
proteins overexpressed at the surface of RMS cells, combined to an intracellular tail optimized for
NK activation. Expanded primary NK cells were transduced and sorted based on CAR expression,
leading to an enriched CAR+
-NK cells population. Efficacy of both CARs was evaluated by cytotoxic
and degranulation assays against RH-30 and RD RMS cell lines, both expressing B7-H3 and FGFR4.
Preliminary results showed an increase in cytotoxicity of 20% compared to wild type NK for CAR
anti-B7-H3. NK cells were also knocked-out for the gene coding for NKG2A, using CRISPR Cas9,
thereby increasing cytotoxicity by 20% to 25%. The combination of both genetic modifications
should significantly increase the efficacy of NK-cell based therapy in RMS. Indeed, preliminary
results allowed us to observe that doubly modified NKs were more than 60% more cytotoxic than
non-transduced NKs and 20% more effective than CAR-NKs or NKs not expressing NKG2A.
This project will be a proof of principle that a highly innovative therapy based on NK-cell
engineering is efficient and applicable to solid cancer.
|
7 |
The Role of Plasmacytoid Dendritic Cells and Natural Killer Cells in Systemic Lupus ErythematosusHagberg, Niklas January 2014 (has links)
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production, which can eventually lead to immune complex (IC)-mediated organ damage. Due to the stimulation of plasmacytoid dendritic cells (pDC) by nucleic acid-containing ICs (DNA- or RNA-IC), patients with SLE have an ongoing interferon (IFN)-α production. IFN-α induces a general activation of the immune system that may initiate or propagate an autoimmune process if not properly regulated. Previous studies have shown that natural killer (NK) cells potently enhance the IFN-α production by pDCs. In study I, the mechanisms behind the NK cell-mediated increased IFN-α production by RNA-IC-stimulated pDCs were investigated. ICs triggered CD56dim NK cells via FcγRIIIA to the secretion of cytokines (e.g. MIP-1β) that promoted IFN-α production. Additionally, an LFA-1-dependent cell-cell interaction between pDCs and NK cells strongly contributed to the increased production of IFN-α. In study II, the RNA-IC-induced regulation of surface molecules on pDCs and NK cells was investigated. The expression of CD319 and CD229, which are two SLAM family receptors genetically associated with SLE, was induced on pDCs and NK cells by RNA-IC. IFN-α-producing pDCs displayed an increased expression of CD319 and CD229, whereas pDCs from patients with SLE had a decreased expression of CD319. In study III, we serendipitously identified an SLE patient harboring autoantibodies to the NK cell receptor CD94/NKG2A. In study IV, sera from 203 patients with SLE were analyzed for autoantibodies to the CD94/NKG2A, CD94/NKG2C and NKG2D receptors. Seven patients harbored anti-CD94/NKG2A autoantibodies, and two of these patient’s autoantibodies also reacted with CD94/NKG2C. Anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies both interfered with the HLA-E-mediated regulation of NK cell cytotoxicity, and facilitated the elimination of target cells expressing these receptors. Furthermore, these autoantibodies were found in a group of severely diseased SLE patients and their titers closely followed disease activity. In conclusion, this thesis provides insights to molecular mechanisms whereby NK cells regulate the IFN-α production, it further links the SLAM receptors to SLE, and it describes novel autoantibodies to receptors regulating NK cell cytotoxicity. Together these findings strengthen the assumption that NK cells are involved in the pathogenesis of SLE.
|
8 |
Exploitation du potentiel thérapeutique des cellules Natural Killer pour traiter les cancersLemieux, William 12 1900 (has links)
Malgré le succès de l’utilisation des lymphocytes T modifiées par des récepteur antigéniques chimériques (CAR) contre les leucémies, celles-ci présentent des limites comme leur risque de CRS et leur inefficacité dans les tumeurs solides. Plusieurs autres immunothérapies cellulaires ont été proposées pour pallier à ces inconvénients. Les cellules natural killer (NK) ont plusieurs propriétés qui en font une alternative avantageuse aux cellules T dans les immunothérapies. Cependant, les cellules NK restent difficiles à modifier avec les outils actuels et leur efficacité reste limitée par les mécanismes immunosuppresseurs des tumeurs. Nous avons réussi à augmenter l’efficacité de transduction avec une nouvelle glycoprotéine, le BaEVRless. Nous avons aussi démontré que cette enveloppe ne provoque pas de modification du phénotype ou de l’activité intrinsèque des cellules NK. Dans un modèle de leucémie, nous avons déterminé que l’utilisation du BaEVRless permet la production de cellules CAR-NK fonctionnelles. Les cellules NK peuvent aussi être transduites efficacement par des constructions lentivirales portant les séquences codant pour deux constructions CAR simultanément. Nous avons aussi démontré que l’édition génomique des NK par la technologie Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) est possible en utilisant une livraison non-virale. Avec cette méthode, nous avons pu réduire l’expression de NKG2A. Les cellules NK avec une expresssion réduite de NKG2A étaient résistantes à l’inhibition par HLA-E, exprimé sur des lignées de cancer du sein et du colon. Cet effet a été confirmé in vivo dans un modèle préclinique xenogénique. Ces résultats montrent deux stratégies qui pourraient permettre d’améliorer les immunothérapies à base de cellules NK. / Despite the overwhelming success of chimeric antigen receptor (CAR)-modified T lymphocytes against leukemias, some limitations have been observed, such as the risk of developing CRS and the lack of efficiency in solid tumor settings. Many other cell-based immunotherapies have been explored to circumvent those caveats. Natural killer (NK) cells present many advantageous properties that could make them a very promising alternative to T cells in immunotherapies. However, NK cells have some caveats, mainly they are hard to modify using conventional tools and they are sensitive to many inhibitory signals expressed by cancer cells. We managed to greatly improve the efficiency of transduction using a novel viral glycoprotein, BaEVRless. In the process, we determined that this novel enveloppe glycoprotein did not modify the phenotype or intrinsic activity of the transduced NK cells. In a leukemia model, we also showed that the BaEVRless can be used to generate functionnal CAR-NK cells. Moreover, the NK cells can be transduced with larger lentiviral constructions bearing two simultaneous CAR-coding sequences. We also demonstrated that Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR) modification of NK cells using a non-viral approach was possible. Using this approach, we generated NK cells with lower NKG2A expression, that were resistant to the inhibitory effects of HLA-E. This affect was seen in a breast cancer model and a colon cancer model. The in vitro results were confirmed in an in vivo preclinical xenogeneic model. Together, those results represent two improvements applicable to NK cell-based immunotherapies.
|
Page generated in 0.0162 seconds